Oncomine Comprehensive Plus panel - (Outlab)

This comprehensive cancer genomic panel evaluates multiple genes and biomarkers linked to solid tumors. It may detect clinically relevant DNA and RNA changes, such as mutations, gene fusions, copy-number changes, tumor mutational burden, and microsatellite instability, depending on the analysis performed. Healthcare professionals may use it to help characterize a tumor, identify potentially actionable molecular alterations, support treatment planning, assess eligibility for targeted therapies or clinical trials, and provide prognostic information alongside other clinical and pathology findings.

This overview is educational. Use the recorded preparation, sample and lab-partner details below for collection guidance, and confirm any missing information before collection.